KNSA today
$96.17-$0.11 (-0.11%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourBearish
1 hourAscending Triangle
15 minAscending Triangle
5 minAscending Triangle
Daily trend turns down below $90.44
Key levels
Resistance$99.31
Support$90.44
Support$84.03
Latest news & SEC filings
SEC FilingKiniksa Pharmaceuticals International, plc filed an insider trading report (Form 4)
NewsKiniksa Pharmaceuticals International Insider Sells Shares Worth $14,330,278
NewsInsider at Kiniksa Pharmaceuticals International sells shares
All KNSA news →About Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is a biopharmaceutical company that develops and sells treatments for cardiovascular and autoinflammatory conditions. Its main product, ARCALYST, is approved in the United States for recurrent pericarditis, CAPS, and DIRA, and is sold through specialty pharmacies. The company also develops antibody candidates targeting IL-1 signaling, including KPL-387 and KPL-1161, and holds rights to abiprubart. It operates in the United States and has licensing arrangements covering parts of Asia.
Based on the company's 10-K filed Feb 24, 2026.
Nasdaq · Healthcare
Kiniksa Pharmaceuticals International, plc (KNSA)
What Is the Price Target for KNSA?
SEPT Low Target
$71.00
SEPT Mid Target
$100.50
SEPT High Target
$122.00
Analyst Consensus
$100.50
Is KNSA a Buy or Sell Right Now?
Thesis
- •Revenue growing 60.1% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KNSA.
Start Free Trial →Is KNSA Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$75.14
49
Moat Score
NARROW
6/9
Piotroski Score
24.6
Altman Z-Score
What Is Smart Money Doing with KNSA?
Insider Signal
NEUTRAL
0 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Megna Michael R | officer | Buy | 11,280 | $200K | Nov 9, 2026 |
| Megna Michael R | officer | Sale | 11,280 | $1.1M | Nov 9, 2026 |
| Patel Sanj K | director officer | Buy | 145,763 | $2.6M | Nov 4, 2026 |
| Patel Sanj K | director officer | Sale | 1,460 | $135K | Nov 4, 2026 |
| Patel Sanj K | director officer | Sale | 11,335 | $1.1M | Nov 4, 2026 |
| Patel Sanj K | director officer | Sale | 81,742 | $7.7M | Nov 4, 2026 |
| Patel Sanj K | director officer | Sale | 29,845 | $2.8M | Nov 4, 2026 |
| Patel Sanj K | director officer | Sale | 26,918 | $2.6M | Nov 4, 2026 |
| Patel Sanj K | director officer | Buy | 89,089 | $787K | Nov 3, 2026 |
| Patel Sanj K | director officer | Buy | 41,237 | $739K | Nov 3, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →KNSA Growth Story
Revenue YoY
60.1%
3yr Revenue CAGR
45.5%
EPS Growth YoY
225%
FCF Growth YoY
436.8%
Revenue Trend
ACCELERATING
Dark Pool Trades for KNSA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for KNSA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:57:15 | $96.58 | 2,928 | $$283K | BUY |
| 14:53:00 | $95.72 | 12,440 | $$1.2M | BUY |
| 21:00:52 | $96.28 | 1,255 | $$121K | BUY |
| 21:00:48 | $96.28 | 1,304 | $$126K | BUY |
| 21:00:44 | $96.28 | 1,386 | $$133K | BUY |
5 dark pool trades shown · $$1.9M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for KNSA
PREVIEWSEPT Investing provides real-time options flow tracking for KNSA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $110 | Nov 20 | 7 | $$120 | 2 | SWEEP |
| CALL | $100 | Nov 20 | 7 | $$170 | 1 | SWEEP |
| CALL | $105 | Nov 20 | 7 | $$500 | 4 | SWEEP |
| CALL | $100 | Nov 20 | 7 | $$420 | 2 | SWEEP |
| CALL | $100 | Nov 20 | 7 | $$1440 | 6 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About KNSA
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for KNSA. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $NMAX — CONYERS INVESTMENTS LLC | Sale $549K $GCMG — SULLIVAN KATHLEEN PATRICIA | Sale $198K $KNSA — Megna Michael R | Sale $369K $APGE — McKenna Mark C. | Sale $APGE — JONES WILLIA...
Join 3,500+ traders discussing KNSA in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Kiniksa Pharmaceuticals International, plc (KNSA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →KNSA — frequently asked questions
What is KNSA stock price today?
Kiniksa Pharmaceuticals International, plc (KNSA) is at $96.17, down 0.11% (-$0.11) at the Nov 13, 2026 close.
Why is KNSA stock moving today?
Latest KNSA news — Nov 12, 2026: Kiniksa Pharmaceuticals International, plc filed an insider trading report (Form 4) · Nov 6, 2026: Kiniksa Pharmaceuticals International Insider Sells Shares Worth $14,330,278
What is the KNSA price target?
The average analyst price target for KNSA is $100.50, ranging from $71 to $122, based on 8 analysts. Latest: JP Morgan maintains on Oct 30, 2026.
What do analysts rate KNSA?
Analyst ratings for KNSA: 0 Buy, 13 Hold, 0 Sell — consensus Hold.
Did KNSA beat earnings?
KNSA last reported on Oct 27, 2026: EPS $0.56 vs $0.37 expected — a beat of 50.9%.
What is KNSA's P/E ratio?
KNSA trades at a P/E of 70.4 vs a Healthcare average of 18.4.
Does KNSA pay a dividend?
KNSA does not currently pay a dividend.
What are KNSA support and resistance levels?
Support: $90.44, $84.03, $77.70. Resistance: $99.31.
What are insiders doing with KNSA?
Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.
What is the latest news on KNSA?
Nov 12, 2026: Kiniksa Pharmaceuticals International, plc filed an insider trading report (Form 4) · Nov 6, 2026: Kiniksa Pharmaceuticals International Insider Sells Shares Worth $14,330,278 · Nov 4, 2026: Insider at Kiniksa Pharmaceuticals International sells shares